Top KHN Original Stories

View More

Total Results: 116

In Blow To Pharma, Maryland Law Punishing Price Gouging Allowed To Go Into Effect

KHN Morning Briefing

A group representing pharmaceutical makers asked a judge to stop the law from going into effect, but U.S. District Judge Marvin Garbis found that “an erroneous grant of a preliminary injunction would cause substantial harm by permitting the sale of essential drugs to Maryland residents at unconscionable prices.”

Health Warnings On Soda Ads Suppresses Free Speech, Judges Rules

KHN Morning Briefing

A San Francisco ordinance would have required a warning on sodas and sugary beverages, but Ninth U.S. Circuit Court of Appeals Judge Sandra Ikuta writes in the ruling that the label is “not purely factual” and “unduly burdens and chills protected commercial speech.”

Post-Surgical Patients Are Rarely The Ones Who Start Long-Term Opioid Use

KHN Morning Briefing

Its more common for those who receive their first prescription for back pain or “other ill-defined conditions” to go on to use painkillers for six months or more, according to new research. In other news related to the national epidemic, the Cherokee Nation asks a judge to allow its lawsuit against opioid distributors and retailers to be heard in the tribe’s own court. And KHN reports that the public health crisis is taking a toll on the nation’s foster care system.

Settlement Finalized Between Mylan, Feds Over Epipen Overcharges To Medicaid

KHN Morning Briefing

The $465 million settlement announced Thursday by the Department of Justice resolves claims that Mylan avoided paying rebates to the government by improperly classifying the EpiPen as a generic drug. Mylan and its auto-injector product have been at the center of the national debate over prescription drug costs.